Becker's Hospital Review RSS

Hundreds of pharmacies are permanently closing their doors as consumer trends change and businesses succumb to financial pressures. 

Cambridge, Mass.-based Beth Israel Lahey Health reported a $138.8 million operating loss (-6.1% margin) for the three months ending Sept. 30, down from a $10.6 million operating gain (0.5% margin) during the same period last year.

Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center opened a $98 million cell and gene therapy hub aimed at growing the center's capabilities for cancer cell therapy research.

A 2023 shortage of the generic platinum-based chemotherapy drugs cisplatin and carboplatin had no effect on cancer mortality rates, according to a study published Dec. 3 in the Journal of the National Cancer Institute.

Pharmacy benefit managers were paid by drugmakers, including Purdue Pharma, to keep opioid prescriptions flowing even as overdose deaths soared across the U.S., according to an investigation by The New York Times. 

Burlington, Mass.-based Tufts Medicine reported an operating loss of $68.2 million (-10.2% margin) in the third quarter, compared to a $61 million loss (-9.6% margin) recorded in the same period in 2023.

Mary Armijo has been appointed COO of Lovelace Medical Center in Albuquerque, N.M., effective Jan. 6.

Bob Carter, MD, PhD, has been named CEO of Salt Lake City-based University of Utah Health and senior vice president for health sciences at the University of Utah, effective mid-February.

Eric Kleinert, MSN, RN, has been named chief administrative officer of Robert Wood Johnson University Hospital Rahway (N.J.), effective Dec. 31.

While many hospital and health system CEOs who took on new roles in 2024 switched organizations or facilities, a few stood out for returning to a former workplace.